Medical News

RSS

Aetna acquires Prodigy Health Group

Aetna today announced that it has completed its acquisition of Prodigy Health Group, the nation's largest independent third party administrator (TPA) of self-funded health care plans.

29 Jun 2011

Global economic recession ends concerted rise in fertility rates

The global economic recession of 2008-09 has been followed by a decline in fertility rates in Europe and the United States, bringing to an end the first concerted rise in fertility rates in the developed world since the 1960s, according to research published today.

29 Jun 2011

Roundup: UMass students complain about insurance plan; Indiana stops paying for children's vaccines; Suit filed to stop Arizona Medicaid cuts

Student leaders at the University of Massachusetts Amherst campus say changes in the students' health insurance plan will unfairly hit hardest on women, low-income students, and those with mental illnesses.

29 Jun 2011

U.Va. and Epsilon partner to provide commercial version of computer-based diabetes simulation tool

A computer-based diabetes simulation tool developed by University of Virginia researchers is now commercially available, thanks to a partnership with the Charlottesville-based medical research firm The Epsilon Group. The simulator is the only protocol that has been accepted by the U.S. Food and Drug Administration as an alternative to animal testing of Type 1 diabetes control strategies.

29 Jun 2011

Insufficient sleep can reduce benefit of hormones released during sleep

Nearly half of all Americans reported having difficulty sleeping. The Center for Disease Control and Prevention has reported that about 35% of people surveyed in 12 states said they slept less than 7 hours a night on average.

29 Jun 2011

Viewpoints: A health law legal precedent, hospital-acquired infections, price cap scrutiny

The Supreme Court's most important ruling this year may have been its unanimous decision in Bond v. United States, which held that individual citizens can challenge federal statutes when they encroach on authority the Constitution reserves to the states. The decision, authored by Justice Anthony Kennedy, has far-reaching implications — especially for the government's efforts to defend ObamaCare.

29 Jun 2011

FDA clears Nuvo's IND for Lidocaine Spray formulation

Nuvo Research Inc., a specialty pharmaceutical company dedicated to building a portfolio of products for the topical treatment of pain, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Company's Investigational New Drug (IND) application filed May 27, 2011 for a novel topical Lidocaine Spray formulation (NRI-ANA), allowing for initiation of Phase 1 studies.

29 Jun 2011

Expert addresses need to improve risk stratification of heart failure patients eligible for ICD or CRT-D

Responding to a recent study showing that 40% of patients who receive CRT-ICD therapy do not benefit from the device (Sipahi, et al – 6/13/11), Wojciech Zareba, MD, PhD, stated that improving risk stratification of heart failure patients eligible for an implantable cardioverter defibrillator (ICD) or cardiac resynchronization therapy with a defibrillator (CRT-D) is essential.

28 Jun 2011

Start of clinical validation study of Down’s syndrome diagnostic test

In conjunction with several Central European prenatal centers, scientists at GATC Biotech AG and LifeCodexx AG have begun the clinical validation study of a non-invasive, prenatal diagnostic test based on next generation sequencing.

28 Jun 2011

bioMD changes name to Allied Healthcare Group

bioMD Limited (ASX: BOD) today announced a change of corporate name to reflect the merger with Allied Medical Ltd earlier this month. The new Company will be called Allied Healthcare Group Ltd and trade under the ASX code AHZ.

28 Jun 2011

IOTA NanoSolutions secures funding for commercialisation of ContraSol technology

IOTA NanoSolutions Limited, a specialist formulation company, is pleased to announce today that it has completed a financing round to support the commercialisation of its proprietary nanodispersion formation technology, ContraSol™. New investor, QIB(UK) Plc joins Unilever Ventures Limited (UV) in this financing round.

28 Jun 2011

Conventional Estrogen Receptor measurement methods may result in 10-20% false negative rate

A team of Yale Cancer Center researchers has confirmed that between 10-20% of breast cancers classified as Estrogen Receptor (ER) negative are really positive. Understanding when and why breast cancers may be misclassified has important implications for treatment and outcomes for women diagnosed with breast cancer. Its findings are published online in the June 28 Journal of Clinical Oncology.

28 Jun 2011

New insights into 'sundowning' syndrome

New research provides the best evidence to date that the late-day anxiety and agitation sometimes seen in older institutionalized adults, especially those with dementia, has a biological basis in the brain.

28 Jun 2011

Screening with mammography reduces deaths from breast cancer

Results from the longest running breast screening trial show that screening with mammography reduces the number of deaths from breast cancer.

28 Jun 2011

Bio-Nucleonics' generic Metastron, an option for metastatic cancer bone pain therapy

Bio-Nucleonics' lead product Strontium Chloride Sr-89 Injection USP (Strontium-89), which is the generic version of Metastron®, is an option to consider for metastatic cancer bone pain therapy, typically caused by advanced stage breast, prostate or lung cancer.

28 Jun 2011

454 Life Sciences launches new GS FLX+ System for high-throughput sequencing

454 Life Sciences, a Roche Company, announced today the launch and immediate availability of the new GS FLX+ System, an instrument capable of generating extra-long sequencing reads up to 1,000 by in length.

28 Jun 2011

AMRI, Proteros ink new partnership

AMRI and Proteros Biostructures GmbH announced today that they have signed an agreement for a joint offering to the life sciences industry. Proteros, an expert in the field of protein crystallization and X-ray structural analysis, provides services that complement AMRI's existing drug discovery capabilities in chemistry, in vitro biology, drug metabolism and pharmacokinetics services.

28 Jun 2011

GM Hospital Group acquires Beijing hospital facility for HK$600,000,000

Golden Meditech Holdings Limited, is pleased to announce the acquisition of a hospital facility in Beijing's Haidian District for a total consideration of HK$600,000,000.

28 Jun 2011

Infection rate drops at Nebraska hospital after initiating new protocols

Nurses, occupational and physical therapists, case managers and education staff, all working together at a 300-bed Nebraska rehabilitation hospital, have successfully implemented a team approach to dramatically reduce infections from urinary catheters, the most prevalent type of infection acquired in healthcare settings.

28 Jun 2011

Tibotec, Gilead Sciences enter license agreement for new combination product of PREZISTA and cobicistat

Tibotec Pharmaceuticals today announced that it has entered into a license agreement with Gilead Sciences, Inc., for the development and commercialization of a new once-daily single tablet fixed-dose antiretroviral combination product containing Tibotec's protease inhibitor PREZISTA® (darunavir) and Gilead's cobicistat, an investigational pharmacoenhancing or "boosting" agent.

28 Jun 2011

Medical News

Aetna acquires Prodigy Health Group

Global economic recession ends concerted rise in fertility rates

Roundup: UMass students complain about insurance plan; Indiana stops paying for children's vaccines; Suit filed to stop Arizona Medicaid cuts

U.Va. and Epsilon partner to provide commercial version of computer-based diabetes simulation tool

Insufficient sleep can reduce benefit of hormones released during sleep

Viewpoints: A health law legal precedent, hospital-acquired infections, price cap scrutiny

FDA clears Nuvo's IND for Lidocaine Spray formulation

Expert addresses need to improve risk stratification of heart failure patients eligible for ICD or CRT-D

Start of clinical validation study of Down’s syndrome diagnostic test

bioMD changes name to Allied Healthcare Group

IOTA NanoSolutions secures funding for commercialisation of ContraSol technology

Conventional Estrogen Receptor measurement methods may result in 10-20% false negative rate

New insights into 'sundowning' syndrome

Screening with mammography reduces deaths from breast cancer

Bio-Nucleonics' generic Metastron, an option for metastatic cancer bone pain therapy

454 Life Sciences launches new GS FLX+ System for high-throughput sequencing

AMRI, Proteros ink new partnership

GM Hospital Group acquires Beijing hospital facility for HK$600,000,000

Infection rate drops at Nebraska hospital after initiating new protocols

Tibotec, Gilead Sciences enter license agreement for new combination product of PREZISTA and cobicistat

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News